Royalty Pharma
RPRX
#747
Rank
โ‚ฌ29.18 B
Marketcap
50,69ย โ‚ฌ
Share price
-1.00%
Change (1 day)
59.31%
Change (1 year)

EPS for Royalty Pharma (RPRX)

EPS in 2026 (TTM): 1,63ย โ‚ฌ

According to Royalty Pharma's latest financial reports the company's current EPS (TTM) is 1,65ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 1,56ย โ‚ฌ a decrease over its 2024 EPS that were of 1,67ย โ‚ฌ.

EPS history for Royalty Pharma from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)1,63ย โ‚ฌ4.46%
20251,56ย โ‚ฌ-6.59%
20241,67ย โ‚ฌ
20201,32ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Abbott Laboratories
ABT
3,13ย โ‚ฌ 89.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
24,49ย โ‚ฌ 1,381.74%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
3,57ย โ‚ฌ 115.76%๐Ÿ‡บ๐Ÿ‡ธ USA